An epidemiologist who has data-offer-url=”https://www.americaoutloud.news/turbo-cancers-other-new-diseases-in-the-covid-vaccine-era/” class=”external-link” data-event-click=”{"element":"ExternalLink","outgoingURL":"https://www.americaoutloud.news/turbo-cancers-other-new-diseases-in-the-covid-vaccine-era/"}” href=”https://www.americaoutloud.news/turbo-cancers-other-new-diseases-in-the-covid-vaccine-era/” rel=”nofollow noopener” target=”_blank”>speculated about whether there is a connection between Covid-19 vaccines and “turbo cancer” in young people, and works as chief epidemiologist at a data-offer-url=”https://www.twc.health/” class=”external-link” data-event-click=”{"element":"ExternalLink","outgoingURL":"https://www.twc.health/"}” href=”https://www.twc.health/” rel=”nofollow noopener” target=”_blank”>company that sells ivermectin alongside reviews that claim it has efficacy as a cancer treatment, has been appointed by president Donald Trump to a key position overseeing the National Cancer Program.
Harvey Risch, a professor emeritus of epidemiology at the Yale School of Public Health, announced his appointment as chair of the…
